Increasing lung cancer screening awareness in Hispanic/LatinX head and neck cancer survivors

GUIAR: PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

This study is trying to see if Hispanic/LatinX survivors of head and neck cancer know about lung cancer screening and what might stop them from getting screened.

Quick facts

• Phase: NA
• Study type: Interventional
• Enrollment: 44 (estimated)
• Ages: 18 Years to 80 Years
• Sex: All
• Sponsor: University of Miami (other)
• Drugs / interventions: radiation
• Locations: 1 site (Miami, Florida)
• Trial ID: NCT06124508 on ClinicalTrials.gov

What this trial studies

This study aims to evaluate the awareness of lung cancer screening eligibility among Hispanic/LatinX survivors of head and neck cancer through a survey questionnaire. It will also explore the barriers to screening by conducting qualitative interviews with participants. The study will provide education on lung cancer screening and assess the implementation of standard care screening programs. By focusing on this specific population, the study seeks to improve access to necessary screenings and ultimately enhance patient outcomes.

Who should consider this trial

Good fit: Ideal candidates for this study are Hispanic/LatinX individuals aged 18 and older who are survivors of head and neck cancer and meet specific lung cancer screening eligibility criteria.

Not a fit: Patients who do not identify as Hispanic/LatinX or who are not survivors of head and neck cancer may not receive any benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to increased awareness and utilization of lung cancer screening among Hispanic/LatinX head and neck cancer survivors, potentially improving early detection and outcomes.

How similar studies have performed: While there may be studies focusing on lung cancer screening in various populations, this specific approach targeting Hispanic/LatinX head and neck cancer survivors is relatively novel.

Eligibility criteria

Inclusion Criteria:

* Participants must be able to understand, and sign informed consent form.
* Age ≥ 18 years.
* Participants must self-identify as Hispanic/LatinX.
* Individuals must be head and neck cancer survivors (treated locally with surgery, radiation alone, or definitive chemoradiation ≥ 5 years earlier and have no signs/symptoms to suggest recurrence of disease).
* Subjects that meet lung cancer (LC) screening eligibility according to United States Preventive Services Task Force (USPSTF21) and/or National Comprehensive Cancer Network (NCCN). For patients with a history of head and neck cancers, the NCCN recommends annual screening with low dose computerized tomography (LDCT) in those who have had a history of 20 pack years of smoking or more. USPSTF21 LC screening eligibility includes adults ages 50-80 that are current smoker or former smokers that quit within 15 years and have a 20 pack-year history or more of smoking.

Exclusion Criteria:

* Individuals with pre-established diagnosis of lung cancer.
* Participants with current diagnosis of any active malignancy.
* Subjects that had undergone lung imaging within previous 3 years.
* Pregnant or nursing mothers.
* Individuals that received head and neck related treatment less than 5 years before screening.
* Individuals with \< 20 pack year history of smoking.
* Subjects with previous history of distant metastatic head and neck cancer.

Where this trial is running

Miami, Florida

• University of Miami — Miami, Florida, United States (RECRUITING)

Study contacts

• Principal investigator: Coral Olazagasti, MD — University of Miami
• Study coordinator: Coral Olazagasti, MD

Conditions: Head and Neck Cancer